Literature DB >> 11315644

Identification and characterization of mutations in the high growth vaccine strain of influenza virus.

K H Lee1, J W Youn, H J Kim, B L Seong.   

Abstract

X-31(H3N2) virus, which is a high yielding reassortant between A/PR/8/34(H1N1) and A/Aichi/68(H3N2), is currently used as a backbone strain for influenza vaccine production. The sequence of the current X-31 virus was determined from cloned cDNA of 6 internal RNA genes, and was compared with the original sequence of the A/PR/8/34 virus. 71 point mutations were accumulated in the six internal viral genes (PB2, PB1, PA, NP, M and NS). These nucleotide changes encode 23 amino acid substitutions in seven viral proteins (PB2, PB1, PA, M1, M2, NS1 and NS2). Among three polymerase genes, a significantly low mutation frequency was observed in PA gene as compared to PB2 and PB1. The mutation frequency at the nucleotide level was significantly low in NP gene without any amino acid substitution, being only about 20% of those observed in 5 other internal genes. The unequal distribution of mutations among different viral proteins may correlate with individual role of each protein in viral growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11315644     DOI: 10.1007/s007050170181

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  8 in total

1.  Influenza virus pleiomorphy characterized by cryoelectron tomography.

Authors:  Audray Harris; Giovanni Cardone; Dennis C Winkler; J Bernard Heymann; Matthew Brecher; Judith M White; Alasdair C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-04       Impact factor: 11.205

2.  A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence.

Authors:  Jonathan A McCullers; Erich Hoffmann; Victor C Huber; Asia D Nickerson
Journal:  Virology       Date:  2005-06-05       Impact factor: 3.616

Review 3.  Prospects on Repurposing a Live Attenuated Vaccine for the Control of Unrelated Infections.

Authors:  Sang-Uk Seo; Baik-Lin Seong
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

4.  Detection of mouse-adapted human influenza virus in the olfactory bulbs of mice within hours after intranasal infection.

Authors:  Jeannine A Majde; Stewart G Bohnet; Georgeann A Ellis; Lynn Churchill; Victor Leyva-Grado; Melissa Wu; Eva Szentirmai; Abdur Rehman; James M Krueger
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

5.  In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins.

Authors:  Zhiguang Ran; Ying Chen; Huigang Shen; Xiaoxiao Xiang; Qinfang Liu; Bhupinder Bawa; Wenbao Qi; Laihua Zhu; Alan Young; Juergen Richt; Wenjun Ma; Feng Li
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

6.  Reverse genetic platform for inactivated and live-attenuated influenza vaccine.

Authors:  Eun Ju Jung; Kwang Hee Lee; Baik Lin Seong
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

7.  Attenuation of the influenza virus sickness behavior in mice deficient in Toll-like receptor 3.

Authors:  Jeannine A Majde; Levente Kapás; Stewart G Bohnet; Alok De; James M Krueger
Journal:  Brain Behav Immun       Date:  2009-10-25       Impact factor: 7.217

8.  The pathogenicity of swan derived H5N1 virus in birds and mammals and its gene analysis.

Authors:  Kairat Tabynov; Abylay Sansyzbay; Nurlan Sandybayev; Muratbay Mambetaliyev
Journal:  Virol J       Date:  2014-11-29       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.